Hakutulokset - Keyue Ding
- Näytetään 1 - 20 yhteensä 41 tuloksesta
- Siirry seuraavalle sivulle
-
1
-
2
LDA—a java-based linkage disequilibrium analyzer Tekijä Keyue Ding, Kaixin Zhou, Fuchu He, Yan Shen
Julkaistu 2003Artigo -
3
-
4
-
5
-
6
-
7
Prognostic and Predictive Role of the VeriStrat Plasma Test in Patients with Advanced Non–Small-Cell Lung Cancer Treated with Erlotinib or Placebo in the NCIC Clinical Trials Group... Tekijä David P. Carbone, Keyue Ding, Heinrich Röder, Julia Grigorieva, Joanna Roder, Ming‐Sound Tsao, Lesley Seymour, Frances A. Shepherd
Julkaistu 2012Artigo -
8
Age and Comorbidity As Independent Prognostic Factors in the Treatment of Non–Small-Cell Lung Cancer: A Review of National Cancer Institute of Canada Clinical Trials Group Trials Tekijä Timothy R. Asmis, Keyue Ding, Lesley Seymour, Frances A. Shepherd, Natasha B. Leighl, Tim Winton, Marlo Whitehead, Johanna N. Spaans, Barbara Graham, Glenwood Goss
Julkaistu 2007Revisão -
9
Adjuvant Vinorelbine and Cisplatin in Elderly Patients: National Cancer Institute of Canada and Intergroup Study JBR.10 Tekijä Carmela Pepe, Baktiar Hasan, Timothy Winton, Lesley Seymour, Barbara Graham, Robert B. Livingston, David H. Johnson, James R. Rigas, Keyue Ding, Frances A. Shepherd
Julkaistu 2007Artigo -
10
Nadir Testosterone Within First Year of Androgen-Deprivation Therapy (ADT) Predicts for Time to Castration-Resistant Progression: A Secondary Analysis of the PR-7 Trial of Intermit... Tekijä Laurence Klotz, Chris J. O’Callaghan, Keyue Ding, Paul Toren, David P. Dearnaley, Celestia S. Higano, Eric M. Horwitz, Shawn Malone, Larry Goldenberg, Mary Gospodarowicz, Juanita Crook
Julkaistu 2015Artigo -
11
Quality-of-Life Outcomes for Adjuvant Chemotherapy in Early-Stage Non–Small-Cell Lung Cancer: Results From a Randomized Trial, JBR.10 Tekijä Andrea Bezjak, Christopher W. Lee, Keyue Ding, Michael Brundage, Timothy Winton, Barbara Graham, Marlo Whitehead, David H. Johnson, Robert B. Livingston, Lesley Seymour, Frances A. Shepherd
Julkaistu 2008Artigo -
12
Gemcitabine, dexamethasone and cisplatin is an active andnon-toxic chemotherapy regimen in relapsed or refractory Hodgkin’s disease: a phase II study by the National Cancer Institu... Tekijä Tara Baetz, Andrew R. Belch, Stephen Couban, Kevin Imrie, J. Yau, Robert E. Myers, Keyue Ding, Narinder Paul, L. E. Shepherd, José Iglesias, Ralph M. Meyer, Michael Crump
Julkaistu 2003Artigo -
13
Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer: Subgroup Analysis of the Lung Adjuvant Cisplatin Evaluation Tekijä Jean-Yves Douillard, Hélène Tribodet, D. Aubert, Frances A. Shepherd, Rafael Rosell, Keyue Ding, Anne-Sophie Veillard, Lesley Seymour, Thierry Le Chevalier, Stephen Spiro, Richard Stephens, Jean‐Pierre Pignon
Julkaistu 2010Artigo -
14
Pooled Analysis of the Effect of Age on Adjuvant Cisplatin-Based Chemotherapy for Completely Resected Non–Small-Cell Lung Cancer Tekijä Martin Früh, Estelle Rolland, Jean‐Pierre Pignon, Lesley Seymour, Keyue Ding, Hélène Tribodet, Timothy Winton, Thierry Le Chevalier, Giorgio V. Scagliotti, Jean-Yves Douillard, Stephen Spiro, Frances A. Shepherd
Julkaistu 2008Artigo -
15
Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non–Small Cell Lung Cancer Treated with Epidermal Growth Factor... Tekijä Alona Zer, Keyue Ding, Siow Ming Lee, Glenwood Goss, Lesley Seymour, Peter Ellis, Allan Hackshaw, Penelope A. Bradbury, Lei Han, Christopher J. O’Callaghan, Ming‐Sound Tsao, Frances A. Shepherd
Julkaistu 2015Artigo -
16
Prognostic and Predictive Value of Epidermal Growth Factor Receptor Tyrosine Kinase Domain Mutation Status and Gene Copy Number for Adjuvant Chemotherapy in Non-small Cell Lung Can... Tekijä Ming‐Sound Tsao, Akira Sakurada, Keyue Ding, Sarit Aviel‐Ronen, Olga Ludkovski, Ni Liu, Aurélie Le Maître, David R. Gandara, David H. Johnson, James R. Rigas, Lesley Seymour, Frances A. Shepherd
Julkaistu 2010Artigo -
17
Class III β-Tubulin Expression and Benefit from Adjuvant Cisplatin/Vinorelbine Chemotherapy in Operable Non–Small Cell Lung Cancer: Analysis of NCIC JBR.10 Tekijä P. Sève, Raymond Lai, Keyue Ding, Timothy Winton, Charles Butts, John R. Mackey, Charles Dumontet, Laith Dabbagh, Sarit Aviel‐Ronen, Lesley Seymour, Marlo Whitehead, Ming‐Sound Tsao, Frances A. Shepherd, Tony Reiman
Julkaistu 2007Artigo -
18
Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Cl... Tekijä Ralph M. Meyer, Mary Gospodarowicz, Joseph M. Connors, R. Pearcey, Andrea Bezjak, Woodrow Wells, Bruce F. Burns, Jane N. Winter, Sandra J. Horning, A. Rashid Dar, Marina Djurfeldt, Keyue Ding, Lois E. Shepherd
Julkaistu 2005Artigo -
19
Association between genetic variation of <i>CACNA1H</i> and childhood absence epilepsy Tekijä Yucai Chen, Jianjun Lu, Hong Pan, Yuehua Zhang, Husheng Wu, Keming Xu, Xiaoyan Liu, Yuwu Jiang, Xinhua Bao, Zhijian Yao, Keyue Ding, Wilson H.Y. Lo, Boqin Qiang, Piu Chan, Yan Shen, Xiru Wu
Julkaistu 2003Artigo -
20
Complement Receptor 1 Gene Variants Are Associated with Erythrocyte Sedimentation Rate Tekijä Iftikhar J. Kullo, Keyue Ding, Khader Shameer, Catherine A. McCarty, Gail P. Jarvik, Joshua C. Denny, Marylyn D. Ritchie, Zi Ye, David R. Crosslin, Rex L. Chisholm, Teri A. Manolio, Christopher G. Chute
Julkaistu 2011Artigo
Työkalut:
Liittyvät aiheet
Medicine
Internal medicine
Oncology
Cancer
Chemotherapy
Biology
Lung cancer
Confidence interval
Gene
Hazard ratio
Genetics
Surgery
Cisplatin
Randomized controlled trial
Vinorelbine
Epidermal growth factor receptor
Cancer research
Paleontology
Pathology
Radiation therapy
Stage (stratigraphy)
Adjuvant
Alternative medicine
Clinical trial
Gastroenterology
Placebo
Genotype
Single-nucleotide polymorphism
Androgen deprivation therapy
Erlotinib